Clinical Trial Update: Phase 4 Study of Dolutegravir (DTG) in Russian Federation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dolutegravir for HIV infection in the Russian Federation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 4 | Status: COMPLETED